Kornelia Polyak is a professor of medicine at Harvard Medical School and an internationally recognized breast cancer expert.[1]
Kornelia Polyak | |
|---|---|
| Alma mater | |
| Scientific career | |
| Institutions | |
Polyak earned her MD from Albert Szent-Gyorgyi Medical University in Szeged, Hungary, and her PhD from Weill Cornell Graduate School of Medical Sciences/Sloan-Kettering Cancer Center in New York City. She then did a fellowship in cancer genetics at Johns Hopkins Oncology Center with Bert Vogelstein and Kenneth Kinzler.[2]
In 1998, Polyak joined the faculty of Dana–Farber Cancer Institute.[2] Her research focuses on breast tumor evolution.[3] Her research is funded in part by the Breast Cancer Research Foundation.[4]
From 2010 to 2013, she served on the American Association for Cancer Research Board of Directors,[2] and from 2015 to 2019, she was a member of the AACR Women in Cancer Research council.[2]
Awards
edit- 2007 AACR 27th Annual Award for Outstanding Achievement in Cancer Research
- 2008 Elected member of the American Society for Clinical Investigation[5]
- 2011 Paul Marks Prize for Cancer Research
- 2012 AACR Outstanding Investigator Award for Breast Cancer Research
- 2015 Outstanding Investigator Award, National Cancer Institute
- 2016 Rosalind Franklin Award
- 2019 AAAS Fellow
- 2020 Fellows of the AACR Academy
- 2020 Distinguished Alumna Award, Weill Cornell Graduate School of Medical Sciences
- 2022 National Academy of Sciences
- 2022 National Academy of Medicine
- 2022 American Cancer Society Research Professor
References
edit- ^ "Kornelia Polyak, MD, PhD - DF/HCC". www.dfhcc.harvard.edu. Retrieved 12 April 2019.
- ^ a b c d "Kornelia Polyak, MD, PhD". www.aacr.org. Retrieved 12 April 2019.
- ^ "Genetics of Breast Cancer". ndriresource.org. Retrieved 12 April 2019.
- ^ "Kornelia Polyak | Researcher". Breast Cancer Research Foundation. 23 June 2014. Retrieved 12 April 2019.
- ^ "The American Society for Clinical Investigation". Retrieved 12 April 2019.